Paclitaxel Injection, Powder, Lyophilized, For Suspension
Product Images NDC 67457-937

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 67457-937). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Paclitaxel Protein-bound Injection 100 mg Carton (Image 01)

The packaging label for Paclitaxel Protein-Bound 100 mg per vial injection, powder, lyophilized for suspension (albumin-bound) by Mylan Institutional LLC. The label includes dosage and storage instructions, warnings, and notes specifying it is for intravenous use only and is a single-dose vial. It highlights that functional properties differ from other paclitaxel products and includes barcodes and manufacturing details.*

FDA Label Image

Figure 1, Preparation Instructions (Image 02)

Illustration showing a vial with its rubber stopper being pierced by a syringe needle, representing preparation of an intravenous injection suspension.*

FDA Label Image

Paclitaxel Structural Formula (Image 03)

Chemical structure of paclitaxel, showing its molecular configuration with multiple rings, hydroxyl groups, acetyl groups, and benzoyl groups. The diagram illustrates the spatial arrangement of the atoms in the paclitaxel molecule.*

FDA Label Image

Figure 1: Kaplan-meier Curve Of Overall Survival (intent-to-treat Population) (Image 04)

A survival curve chart comparing the proportion of survival over time in months for two groups: patients treated with paclitaxel protein-bound particles for injectable suspension combined with gemcitabine, and patients treated with gemcitabine alone. The chart includes a legend, survival curves, and the number of patients at risk at various time points up to 39 months.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.